NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 12/02/22

Short Squeeze Penny Stocks to Watch Before Next Week There’s no shortage of volatility in the stock market today. Penny stocks are some of the assets that demonstrate this phenomenon. Today we’ll talk about a few more companies that have seen more significant bearish bets placed...

3 Factors to Consider When Buying Biotech Penny Stocks Penny stocks in the biotech sector can be a great way to make money in the stock market. While these stocks are often overlooked by major investors, they can offer huge returns if you know what to look for. Here are three reasons wh...

Palm Beach, FL – November 10, 2022 – FinancialNewsMedia.com News Commentary – The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market competition, the market participants are implementing methods including increased ...

NEUROBO ANNOUNCES CLOSING OF $32.3 MILLION UNDERWRITTEN PUBLIC OFFERING INCLUDING FULL EXERCISE OF OVERALLOTMENT OPTION AND CONCURRENT PRIVATE PLACEMENT PR Newswire CLOSES EXCLUSIVE LICENSE OF ASSETS FROM DONG-A BOSTON , Nov. 8, 2022 /PRNewswi...

NeuroBo Pharmaceuticals ( NASDAQ: NRBO ) stock fell ~43% on Friday after the company priced a public offering to raise gross proceeds of ~$30M. The offering consists of ~2.4M class A units priced at $3 apiece, with each unit consisting of one common stock, a Series A...

NEUROBO ANNOUNCES PRICING OF $30 MILLION UNDERWRITTEN PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT PR Newswire BOSTON , Nov. 4, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) (the "Company" or "NeuroBo") today announced the pric...

NeuroBo Pharmaceuticals ( NASDAQ: NRBO ) received Nasdaq notification indicating that the company has evidenced full compliance with the minimum bid price requirement As a result, the listing matter has been closed. Shares are trading up 4% premarket. For fur...

NeuroBo Pharmaceuticals, Inc. Compliant with All Applicable Nasdaq Listing Criteria PR Newswire BOSTON , Sept. 29, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. ("NeuroBo") (Nasdaq: NRBO) today announced that on September 27, 2022 , NeuroBo recei...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Alextype/Shutterstock.com Traders continue to show interest in short squeeze stocks this week as they seek out likely targets to push higher. This has us checking out Fintel’s Short Squeeze Leaderb...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is rocketing higher on Thursday as investors react to news of a new heart monitor patent . This new patent covers a 12-lead electro...